Old Web
English
Sign In
Acemap
>
authorDetail
>
Deborah Chirnomas
Deborah Chirnomas
Harvard University
Medicine
Immunology
Deferasirox
Cmax
Pharmacokinetics
8
Papers
266
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Potent and Orally Bioavailable BCL6 PROTAC TM Degraders Demonstrate Efficacy in Pre-Clinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)
2021
Blood
Sheryl M. Gough
Dan Sherman
Lynn B. DeCarr
Sarah Eaton
Maja Milanović
Mark Bookbinder
Jennifer Pizzano
Martha Altieri
John P. Corradi
Hong Xiao
Felipe Gallego
Leofal Soto
Ram Lingamaneni
Xin Chen
Wei Zhang
Gan Wang
Hanqing Dong
Deborah Chirnomas
Michael Berlin
Keith R. Hornberger
Lawrence Snyder
Ian Taylor
Show All
Source
Cite
Save
Citations (0)
A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload.
2010
Blood
Hugh Y. Rienhoff
ip Viprakasit
Lay H. Tay
Paul Harmatz
Elliott Vichinsky
Deborah Chirnomas
Janet L. Kwiatkowski
Amy E. Tapper
John B. Porter
Ellis J. Neufeld
Show All
Source
Cite
Save
Citations (0)
Screening of small molecule inhibitors of the Fanconi Anemia-BRCA pathway
2005
Cancer Research
Toshiyasu Taniguchi
Maria Vasserman
Deborah Chirnomas
Alan D. DAndrea
Show All
Source
Cite
Save
Citations (0)
1